Ramírez-Quesada, W, Alvarado-Tapias, E, Shalaby, S, Hernández-Gea, V. Recompensation in Cirrhosis: Biomarkers and Strategies. SEMINARS IN LIVER DISEASE. 2025; 45(01)DOI:10.1055/a-2542-9930. PMID:40179966. IF:3.700(Q2/3D).

Idalsoaga, F, Díaz, LA, Dunn, W, Mehta, H, Muñoz, K, Caldentey, V, Arnold, J, Ayares, G, Mortuza, R, Sarin, SK, Maiwall, R, Zhang, W, Qian, S, Simonetto, D, Singal, AK, Elfeki, MA, Ramirez-Cadiz, C, Malhi, G, Ahmed, A, Homsi, H, Abid, Z, Cabezas, J, Echavarría, V, Poca, M, Soriano, G, Cuyas, B, Cots, MV, Higuera-De La Tijera, MF, Ayala-Valverde, M, Perez, D, Gomez, J, Abraldes, JG, Al-Karaghouli, M, Jalal, PK, Ibrahim, MA, García-Tsao, G, Goyes, D, Skladany, L, Havaj, DJ, Sulejova, K, Selcanova, SA, Rincón, D, Chacko, KR, Restrepo, JC, Yaquich, P, Toro, LG, Shah, V, Arrese, M, Kamath, PS, Bataller, R, Arab, JP. Moderate alcohol-associated hepatitis: A real-world multicenter study. Hepatology Communications. 2025; 9(4)DOI:10.1097/HC9.0000000000000673. PMID:40131003. IF:4.600(Q1/2D).

Becerra-Aparicio, F, Gómez-Zorrilla, S, Hernández-García, M, Xanthopoulou, K, Gijón, D, Siverio, A, Berbel, D, Cercenado, E, Rivera, A, De Malet, A, Xercavins, M, De Gopegui, ER, Canoura-Fernández, L, Martínez, JA, Seral, C, Del Pozo, JL, Cotarelo, M, Ponz, R, Higgins, PG, Durán-Jordà, X, Cantón, R, Oliver, A, Horcajada, JP, Ruiz-Garbajosa, P. Whole Genome Sequencing Analysis of Klebsiella pneumoniae Isolates from Health Care-Associated Bacteremia of Urinary Origin in Spain: Findings from the Multicenter ITUBRAS-2 Cohort Study. Open Forum Infectious Diseases. 2025; 12(4)DOI:10.1093/ofid/ofaf164. PMID:40201725. IF:3.800(Q1/3D).

Oscullo, G, Méndez, R, Olveira, C, Girón, R, García-Clemente, M, Máiz, L, Sibila, O, Golpe, R, Rodríguez-Hermosa, J, Barreiro, E, Prados, C, Rodríguez-López, JL, de la Rosa-carrillo, D, Martinez-García, MA. Effect of N-Acetylcysteine on Bronchiectasis in a Real-life Study. Data From the Spanish RIBRON Registry. ARCHIVOS DE BRONCONEUMOLOGIA. 2025; 61(4)DOI:10.1016/j.arbres.2025.02.015. PMID:40180519. IF:9.200(Q1/1D).

Zapater, A, Pinilla, L, Gracia-Lavedan, E, Targa, A, Torres, G, Mínguez, O, Pascual, L, Cortijo, A, Martínez, D, Benítez, ID, García-Hidalgo, MC, De Batlle, J, Abad, J, Duran-Cantolla, J, Urrutia, A, Mediano, O, Masdeu, MJ, Ordax-Carbajo, E, Masa, JF, De la Peña, M, Mayos, M, Coloma, R, Montserrat, JM, Chiner, E, Roncero, A, Sanz-Rubio, D, Barbé, F, Sánchez-de-la-Torre, M. Unraveling the Molecular Mechanisms of OSA-Related Cardiovascular Event Recurrence: A Post Hoc Analysis From the ISAACC Study. ARCHIVOS DE BRONCONEUMOLOGIA. 2025; 61(4)DOI:10.1016/j.arbres.2024.09.008. PMID:39438203. IF:9.200(Q1/1D).

Bermudo-Peloche, G, Del Rio, B, Vicens-Zygmunt, V, Bordas-Martinez, J, Hernández, M, Valenzuela, C, Laporta, R, Bobillo, JR, Portillo, K, Millán-Billi, P, Balcells, E, Badenes-Bonet, D, Bolivar, S, Rodríguez-Portal, JA, Ramirez, CL, Tomás, L, Roitegi, KFD, Sellarés, J, Castillo, D, González, J, Barril, S, Gutiérrez-Rodríguez, Y, Caballero, P, Alarcon, J, Peñafiel, J, Sanz-Santos, J, Blavia, R, Caupena, C, Segovia, P, Santos-Pérez, S, Ferrer-Artola, A, Badia, MB, Hereu, P, Fuentes, M, Montes-Worboys, A, Franquet, T, Luburich, P, Molina-Molina, M. Pirfenidone in post-COVID-19 pulmonary fibrosis (FIBRO-COVID): a phase 2 randomised clinical trial. EUROPEAN RESPIRATORY JOURNAL. 2025; 65(4)DOI:10.1183/13993003.02249-2024. PMID:40154560. IF:21.000(Q1/1D).

Rogg, L, Nuñez, SA, Mingrone, MVO, Domingo, P, Lopez, M, Hanan, N, Ghita, GL, Jeffrey, JL, Underwood, M, Castillo-Mancilla, JR, Halliday, F, Ezeadi, E, Gartland, M. Antiviral effect, safety, and tolerability of the third-generation integrase strand transfer inhibitor VH4524184 (VH-184): a proof-of-concept trial. HIV MEDICINE. 2025; 26DOI:. PMID:. IF:3.200(Q2/4D).

Tibau, A, Romano, A, Kesselheim, AS. Will I feel better? Raising the bar for quality of life in oncology. Nature Reviews Clinical Oncology. 2025; 22(4)DOI:10.1038/s41571-025-01002-4. PMID:40021787. IF:82.200(Q1/1D).

Del Muro, XG, López-Bravo, DP, Cuéllar-Rivas, MA, Maroto, P, Giannatempo, P, Castellano, D, Climent, MA, Valderrama, BP, de Liaño, AG, López-Montero, L, Mina, L, Alcalá-López, D, Sampayo-Cordero, M, Necchi, A. Retifanlimab in Advanced Penile Squamous Cell Carcinoma: The Phase 2 ORPHEUS Study. European Urology Oncology. 2025; 8(2)DOI:10.1016/j.euo.2024.04.021. PMID:38749903. IF:9.300(Q1/1D).

Soo, RA, Vervita, K, Früh, M, Cho, B, Majem, M, Abreu, DR, Ribi, K, Callejo, A, Moran, T, Gomez, MD, Provencio, M, Addeo, A, Han, JY, Granados, ALO, Reck, M, Blasco, A, Campelo, RG, González, MAS, Britschgi, C, Roschitzki-Voser, H, Ruepp, B, Gasca-Ruchti, A, Haberecker, M, Dafni, U, Peters, S, Stahel, RA. A randomised non-comparative phase II study of atezolizumab, bevacizumab and chemotherapy in EGFR-mutant NSCLC with acquired resistance - The ETOP 15-19 ABC-lung trial. LUNG CANCER. 2025; 202DOI:10.1016/j.lungcan.2025.108454. PMID:40023017. IF:4.400(Q1/2D).

Holgado, A, Casasayas, M, Llansana, A, Gras, JR. Woake's Syndrome Abscessed in Adults: Case Report. Indian Journal of Otolaryngology and Head & Neck Surgery. 2025; 77(4)DOI:10.1007/s12070-024-05285-4. PMID:40226287. IF:0.054(Q4/10D).

Spyridonidis, A, Labopin, M, Savani, BP, Kulagin, A, Blaise, D, Broers, AEC, Sica, S, Raiola, AM, Vydra, J, Choi, G, Rovira, M, Kwon, M, Sanz, J, Itäla-Remes, M, von dem Borne, P, Esquirol, A, Koc, Y, Brissot, E, Nagler, A, Mohty, M, Ciceri, F. The impact of individual comorbidities in transplant recipients receiving post-transplant cyclophosphamide. BONE MARROW TRANSPLANTATION. 2025; 60(4)DOI:10.1038/s41409-025-02514-4. PMID:39910175. IF:5.200(Q1/1D).

Valle-Tamayo, N, Aranha, MR, Pérez-González, R, Serrano-Requena, S, Videla, L, Barroeta, I, Benejam, B, Chiva-Blanch, G, Jimenez, A, Busciglio, J, Wisniewski, T, Do Carmo, S, Alvarez-Sánchez, E, Muñoz, L, Bejanin, A, Belbin, O, Alcolea, D, Carmona-Iragui, M, Lleó, A, Cuello, AC, Fortea, J, Dols-Icardo, O, Iulita, MF. Nerve growth factor precursor alterations in neuron-derived extracellular vesicles from individuals with Down syndrome along the Alzheimer's disease continuum. ALZHEIMERS & DEMENTIA. 2025; 21(4)DOI:10.1002/alz.70137. PMID:40257051. IF:11.100(Q1/1D).

Kac, PR, Alcolea, D, Montoliu-Gaya, L, Fernández, S, Rodriguez, JL, Maure, L, González-Ortiz, F, Benejam, B, Turton, M, Barroeta, I, Harrison, P, Videla, L, Ashton, NJ, Lleó, A, Zetterberg, H, Carmona-Iragui, M, Karikari, TK, Fortea, J, Blennow, K. Plasma p-tau212 as a biomarker of sporadic and Down syndrome Alzheimer's disease. ALZHEIMERS & DEMENTIA. 2025; 21(4)DOI:10.1002/alz.70172. PMID:40275833. IF:11.100(Q1/1D).

Castro, JG, Rubio-Guerra, S, Casaletto, KB, González, JS, Memel, M, Vaqué-Alcázar, L, Morcillo-Nieto, A, Arriola-Infante, J, Dols-Icardo, O, Bejanin, A, Belbin, O, Fortea, J, Alcolea, D, Carmona-Iragui, M, Barroeta, I, Santos-Santos, M, Saudinós, MBS, Matavera, IS, Heuer, HW, Forsberg, LK, Kantarci, K, Staffaroni, AM, Tartaglia, C, Rankin, KP, Boeve, B, Boxer, A, Rosen, HJ, Lleó, A, Illán-Gala, I. Sex differences in the executive and behavioral reserve of autosomal dominant frontotemporal dementia. ALZHEIMERS & DEMENTIA. 2025; 21(4)DOI:10.1002/alz.70070. PMID:40277045. IF:11.100(Q1/1D).

Boyle, R, Koops, EA, Ances, B, Andrews, EJ, Arenaza-Urquijo, EM, Benjanin, A, Brickman, AM, Buckley, RF, Clas, GS, Costello, E, Coughlan, GT, Conley, AC, Deng, F, Faria, DD, Edwards, N, Flores-Aguilar, L, Fortea, J, Saidi, LG, Head, E, Hom, CL, Koenig, K, Lao, PT, Lengyel, I, Li, YJ, Loi, S, Loughrey, D, Mcglinchey, E, Newhouse, P, Pertierra, L, Prokopiou, PC, Qi, Q, Resende, EDF, Russell, J, Scanlon, CE, Schneider, C, Schultz, SA, Seto, M, Shaka, S, Soldan, A, Alcazar, LV, Weng, YH, Wilson, JE, Zaman, SH, Zsadanyi, SE, Hartley, S. Resistance and resilience to Alzheimer's disease in Down syndrome. ALZHEIMERS & DEMENTIA. 2025; 21(4)DOI:10.1002/alz.70151. PMID:40289889. IF:11.100(Q1/1D).

Liu, XL, de Boer, SCM, Cortez, K, Poos, JM, Illán-Gala, I, Heuer, H, Forsberg, LK, Casaletto, K, Memel, M, Appleby, BS, Barmada, S, Bozoki, A, Clark, D, Cobigo, Y, Darby, R, Dickerson, BC, Domoto-Reilly, K, Galasko, DR, Geschwind, DH, Ghoshal, N, Graff-Radford, NR, Grant, IM, Hsiung, GYR, Honig, LS, Huey, ED, Irwin, D, Kantarci, K, Léger, GC, Litvan, I, Mackenzie, IR, Masdeu, JC, Mendez, MF, Onyike, CU, Pascual, B, Pressman, P, Bayram, E, Ramos, EM, Roberson, ED, Rogalski, E, Bouzigues, A, Russell, LL, Foster, PH, Ferry-Bolder, E, Masellis, M, van Swieten, J, Jiskoot, L, Seelaar, H, Sanchez-Valle, R, Laforce, R, Graff, C, Galimberti, D, Vandenberghe, R, de Mendonça, A, Tiraboschi, P, Santana, I, Gerhard, A, Levin, J, Sorbi, S, Otto, M, Pasquier, F, Ducharme, S, Butler, CR, Le Ber, I, Finger, E, Rowe, JB, Synofzik, M, Moreno, F, Borroni, B, Boeve, BF, Boxer, AL, Rosen, HJ, Pijnenburg, YAL, Rohrer, JD, Tartaglia, MC. Sex differences in clinical phenotypes of behavioral variant frontotemporal dementia. ALZHEIMERS & DEMENTIA. 2025; 21(4)DOI:10.1002/alz.14608. PMID:40277074. IF:11.100(Q1/1D).

Memel, M, Staffaroni, AM, Ilan-Gala, I, Castro, JG, Kornak, J, Tartaglia, CM, Saloner, R, VandeBunte, AM, Paolillo, EW, Cadwallader, CJ, Chen, C, Gorno-Tempini, ML, Mandelli, M, Apostolova, L, Graff-Radford, N, Litvan, I, Bayram, E, Pressman, PS, Miyagawa, T, Mackenzie, I, Goldman, J, Darby, RR, Appleby, BS, Petrucelli, L, Gendron, T, Heuer, HW, Forseberg, LK, Rojas, JC, Boeve, BF, Brushaber, N, Domoto-Reilly, K, Ghoshal, N, Lapid, M, Pascual, B, Lee, S, Ramos, EM, Ramanan, V, Rademakers, R, Rascovsky, K, Pantelyat, A, Masdeu, JC, Snyder, A, Boxer, AL, Rosen, HJ, Casaletto, K. Sex differences in the clinical manifestation of autosomal dominant frontotemporal dementia. ALZHEIMERS & DEMENTIA. 2025; 21(4)DOI:10.1002/alz.14630. PMID:40277077. IF:11.100(Q1/1D).

Vidal-Calés, P, Bujak, K, Rinaldi, R, Salazar-Rodríguez, A, Ortega-Paz, L, Gómez-Lara, J, Jiménez-Díaz, V, Jiménez, M, Jiménez-Quevedo, P, Diletti, R, Bordes, P, Campo, G, Silvestro, A, Maristany, J, Flores, X, De Miguel-Castro, A, Iñiguez, A, Ielasi, A, Tespili, M, Lenzen, M, Gonzalo, N, Tebaldi, M, Biscaglia, S, Romaguera, R, Gómez-Hospital, JA, Serruys, PW, Sabaté, M, Brugaletta, S. Long-term prognostic impact of the left anterior descending coronary artery as the STEMI-related culprit vessel: subanalysis of the EXAMINATION-EXTEND trial. REC, interventional cardiology. 2025; 7(2)DOI:10.24875/RECICE.M24000488. PMID:. IF:(Q/D).

Sivera Mascaró R, García Sobrino T, Horga Hernández A, Pelayo Negro AL, Alonso Jiménez A, Antelo Pose A, Calabria Gallego MD, Casasnovas C, Cemillán Fernández CA, Esteban Pérez J, Fenollar Cortés M, Frasquet Carrera M, Gallano Petit MP, Giménez Muñoz A, Gutiérrez Gutiérrez G, Gutiérrez Martínez A, Juntas Morales R, Ciano-Petersen NL, Martínez Ulloa PL, Mederer Hengstl S, Millet Sancho E, Navacerrada Barrero FJ, Navarrete Faubel FE, Pardo Fernández J, Pascual Pascual SI, Pérez Lucas J, Pino Mínguez J, Rabasa Pérez M, Sánchez González M, Sotoca J, Rodríguez Santiago B, Rojas García R, Turon-Sans J, Vicent Carsí V, Sevilla Mantecón T. Clinical practice guidelines for the diagnosis and management of Charcot-Marie-Tooth disease.. Neurologia. 2025; 40(3)DOI:10.1016/j.nrleng.2024.02.008. PMID:38431252. IF:(Q/D).